Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrainger plc Regulatory News (GRI)

Share Price Information for Grainger plc (GRI)

Share Price is delayed by 15 minutes
Get Live Data
164.60    0.10 (0.06%)
Bid:
164.00
Ask:
164.10
Spread: 0.10 (0.061%)
Market Cap: £1.22b
GRI Live PriceLast checked at - London Stock Exchange

Intraday Grainger plc Share Chart

Director/PDMR Shareholding

13 Dec 2022 13:46

RNS Number : 5758J
Grainger PLC
13 December 2022
 

GRAINGER PLC

("GRAINGER" OR THE "COMPANY")

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

GRANT OF OPTIONS UNDER THE GRAINGER PLC DEFERRED BONUS SHARE PLAN

The Company announces that it has made the following grants of nil cost share options ("Options") over ordinary shares of 5p each in the capital of the Company ("Shares") pursuant to the Deferred Bonus Share Plan ("DBSP") on 12 December 2022. The Options have been granted in respect of the compulsory deferral of 25% of the 2022 annual bonus into Shares for a period of 3 years.

Grant of Options

On 12 December 2022, Grainger granted Options over a total of 152,425 Shares to its Executive Directors and Persons Discharging Managerial Responsibilities ("PDMRs") of the Company (as specified in the table below).

Name of Director/ PDMR

Position

No. of shares under Option

Helen Gordon

Chief Executive Officer (Director)

71,609

Rob Hudson 

Chief Financial Officer (Director)

50,197

Michael Keaveney

Director of Land and Development (PDMR)

20,413

Eliza Pattinson

Director of Operations and Asset Management (PDMR)

10,206

 

Vesting of the Options is not subject to any performance conditions and, subject to continued employment with Grainger, the Options will normally become exercisable after the three-year vesting period.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Helen Gordon

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer / Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 Grainger plc

b)

 

LEI

 

 2138007CEIRKZMNI2979

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary Shares of £0.05 each

 

b)

 

Identification code

 

 ISIN: GB00B04V1276

c)

 

Nature of the transaction

 

Grant of nil cost Option over Ordinary Shares pursuant to the Deferred Bonus Share Plan

d)

 

Price(s) and volume(s)

 

 

 Price(s)

 

Volume(s)

1. £nil

 

1. 71,609

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A

 

 

f)

 

Date of the transaction

 

12 December 2022

g)

 

Place of the transaction

 

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rob Hudson

2

Reason for the notification

a)

Position/status

 

Chief Financial Officer / Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 Grainger plc

b)

 

LEI

 

 2138007CEIRKZMNI2979

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary Shares of £0.05 each

 

b)

 

Identification code

 

 ISIN: GB00B04V1276

c)

 

Nature of the transaction

 

Grant of nil cost Option over Ordinary Shares pursuant to the Deferred Bonus Share Plan

d)

 

Price(s) and volume(s)

 

 

 Price(s)

 

Volume(s)

1. £nil

 

1. 50,197

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A

 

 

f)

 

Date of the transaction

 

12 December 2022

g)

 

Place of the transaction

 

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Michael Keaveney

2

Reason for the notification

a)

Position/status

 

Director of Land and Development / PDMR

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 Grainger plc

b)

 

LEI

 

 2138007CEIRKZMNI2979

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary Shares of £0.05 each

 

b)

 

Identification code

 

 ISIN: GB00B04V1276

c)

 

Nature of the transaction

 

Grant of nil cost Option over Ordinary Shares pursuant to the Deferred Bonus Share Plan

d)

 

Price(s) and volume(s)

 

 

 Price(s)

 

Volume(s)

1. £nil

 

1. 20,413

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A

 

 

f)

 

Date of the transaction

 

12 December 2022

g)

 

Place of the transaction

 

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Eliza Pattinson

2

Reason for the notification

a)

Position/status

 

Director of Operations and Asset Management / PDMR

 

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

 Grainger plc

b)

 

LEI

 

 2138007CEIRKZMNI2979

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

 

 Ordinary Shares of £0.05 each

 

b)

 

Identification code

 

 ISIN: GB00B04V1276

c)

 

Nature of the transaction

 

Grant of nil cost Option over Ordinary Shares pursuant to the Deferred Bonus Share Plan

d)

 

Price(s) and volume(s)

 

 

 Price(s)

 

Volume(s)

1. £nil

 

1. 10,206

 

e)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A

 

 

f)

 

Date of the transaction

 

12 December 2022

g)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPGWCPUPPGWW
Date   Source Headline
1st Apr 20201:50 pmRNSBlock listing Interim Review
25th Mar 20203:05 pmRNSHolding(s) in Company
23rd Mar 20205:09 pmRNSHolding(s) in Company
10th Mar 20204:24 pmRNSTotal Voting Rights
10th Mar 20207:00 amRNSNotice of Interim Results
6th Mar 202012:11 pmRNSDirector/PDMR Shareholding
3rd Mar 202010:30 amRNSDirector/PDMR Shareholding
24th Feb 20203:22 pmRNSAdditional Listing
18th Feb 202010:47 amRNSHolding(s) in Company
18th Feb 20207:00 amRNSAcquisition
17th Feb 202011:57 amRNSDirector/PDMR Shareholding
13th Feb 20203:53 pmRNSResults of Placing
13th Feb 20207:00 amRNSPlacing to accelerate PRS growth strategy
6th Feb 20203:44 pmRNSDirector/PDMR Shareholding
6th Feb 202012:37 pmRNSDirector/PDMR Shareholding
5th Feb 20203:52 pmRNSResult of AGM
5th Feb 20207:00 amRNSTrading Update
8th Jan 202012:15 pmRNSDirector/PDMR Shareholding
20th Dec 20197:00 amRNSPlanning consent granted in Waterloo, London
12th Dec 20199:43 amRNSDirector/PDMR Shareholding
6th Dec 201912:33 pmRNSDirector/PDMR Shareholding
6th Dec 201912:30 pmRNSTotal Voting Rights
5th Dec 20197:00 amRNSAcquisition of Capital Quarter, Cardiff for c.£57m
3rd Dec 20197:00 amRNSDividend Declaration
28th Nov 20197:00 amRNSAcquisition
27th Nov 20197:00 amRNSFull-year audited financial results
22nd Nov 20193:17 pmRNSHolding(s) in Company
19th Nov 20197:00 amRNSPlanning application submitted Besson St, Lewisham
6th Nov 20194:29 pmRNSDirector/PDMR Shareholding
15th Oct 20197:00 amRNSNotice of Full Year Results
14th Oct 20193:57 pmRNSTotal Voting Rights
7th Oct 20194:41 pmRNSDirector/PDMR Shareholding
2nd Oct 201912:22 pmRNSBlock listing Interim Review
2nd Oct 201912:20 pmRNSBlock listing Interim Review
1st Oct 201911:40 amRNSHolding(s) in Company
30th Sep 201911:18 amRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSAcquisition
27th Sep 20197:00 amRNSTrading Update
24th Sep 201911:35 amRNSAdditional Guarantor Notice
24th Sep 201911:28 amRNSGuarantor Resignation Notice
24th Sep 201911:26 amRNSExcluded Entity Resignation Notice
12th Sep 20194:31 pmRNSHolding(s) in Company
12th Sep 201912:21 pmRNSDirector/PDMR Shareholding
10th Sep 20194:00 pmRNSDirector/PDMR Shareholding
6th Aug 20194:27 pmRNSDirector/PDMR Shareholding
6th Aug 20194:26 pmRNSTotal Voting Rights
19th Jul 20197:01 amRNSResponse to Mayor of London's comments
19th Jul 20197:00 amRNSGRIP Portfolio Debt Refinancing
15th Jul 20197:00 amRNSAcquisition Update
9th Jul 20197:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.